SAB Biotherapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SABS and other ETFs, options, and stocks.About SABS
SAB Biotherapeutics, Inc. is a clinical-stage, biopharmaceutical company, which engages in advancing a new class of immunotherapies leveraging fully-human polyclonal antibodies. It produces human polyclonal immunotherapies and its versatile DiversitAb platform is applicable for unmet needs in human diseases.
SABS Key Statistics
Stock Snapshot
The current SAB Biotherapeutics(SABS) stock price is $3.51, with a market capitalization of 268.01M. The stock trades at a price-to-earnings (P/E) ratio of -1.42.
As of 2026-07-20, SAB Biotherapeutics(SABS) stock has fluctuated between $3.47 and $3.62. The current price stands at $3.51, placing the stock +1.2% above today's low and -3.0% off the high.
The SAB Biotherapeutics(SABS)'s current trading volume is 444.8K, compared to an average daily volume of 511.67K.
In the last year, SAB Biotherapeutics(SABS) shares hit a 52-week high of $6.60 and a 52-week low of $1.85.
In the last year, SAB Biotherapeutics(SABS) shares hit a 52-week high of $6.60 and a 52-week low of $1.85.
Analyst ratings
100%
of 12 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.